Alpine Associates Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Alpine Associates Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-544,039	Closed	-$64.4M	–	77
2021 Q1	$64.4M	Buy	544,039 +9,859	+2%	+$1.17M	1.75%	20
2020 Q4	$63.1M	Buy	+534,180	New	+$62M	2.58%	15

Alpine Associates Management's CBPO Position: Q2 2021 in Review

Alpine Associates Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 544,039 shares — an estimated $64.4M sold.

Alpine Associates Management first reported a position in CBPO in Q4 2020 and held it in 2 quarters. The position peaked at $64.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Alpine Associates Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Alpine Associates Management sold 544,039 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $64.4M.
Alpine Associates Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 2 quarters.
Alpine Associates Management's China Biologic Products Holdings, Inc. position peaked at $64.4M in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Alpine Associates Management's 13F filing for Q2 2021, filed 11 Aug 2021.